Published: 2021-12-27

Epidemiology, evaluation and management of tinea pedis

Ohoud Adel Turkistani, Abdullah Ali Aljalfan, Meshal Mohammed Albaqami, Mohammad Mubarak Alajmi, Abdullaziz Mohammed Bahayan, Anwar Ajlan Alqurashi, Renad Mutlaq Alhanaki, Fatema Fahad Alkhalfan, Azzam Meteb Alsharif, Ali Hassan Alkhabbaz, Amal Abdulrahman Alsuwaidi


Tinea pedis, known as athletics foot, is defined as a dermatophyte infection leading to a condition called dermatophytosis. Usually, the mode of infection is fungal. Trichophyton rubrum is the most common organism which is responsible for the infection. This fungus is endemic in some geographical regions as in Asia and Africa. The mode of transmission and risk factors depends on several factors: the weather, type of clothes and shoes, body response to different organisms, present history, family history, and endemic geographical areas. Increased temperature and humidity were correlated in the literature to the increased incidence and prevalence of tinea pedis compared to those areas which have low temperature, wearing specific types of shoes or clothes might be associated with an increased rate of infection, especially if the shoes are adherent to the foot and occlusive, prolonged exposure to humidity and water was also shown to be among the causes for tinea pedis infections. The clinical presentation of tinea pods varies according to the site and severity of infection. Generally, antifungal drugs are effective in most cases. The application of antifungals may be in oral form or local form, or mixed form. Terbinafine was proven to be effective in mild cases to fully treat the infection within a period of one week, extending to four weeks in more aggressive cases. This was a brief look at the article. This article aimed to review tinea pedis from different prospections clinically.


Tinea pedis, Epidemiology, Clinical picture

Full Text:



Ilkit M, Durdu M. Tinea pedis: the etiology and global epidemiology of a common fungal infection. Crit Rev Microbiol. 2015;41(3):374-88.

Nigam PK, Saleh D. Tinea Pedis. In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC. 2021.

Kaushik N, Pujalte GG, Reese ST. Superficial Fungal Infections. Prim Care. 2015;42(4):501-16.

Leyden JL. Tinea pedis pathophysiology and treatment. J Am Acad Dermatol. 1994;31(3 Pt 2):S31-3.

Oz Y, Qoraan I, Oz A, Balta I. Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey. Int J Dermatol. 2017;56(1):68-74.

Kiraz N, Metintas S, Oz Y. The prevalence of tinea pedis and tinea manuum in adults in rural areas in Turkey. Int J Environ Health Res. 2010;20(5):379-86.

English MP, Turvey J. Studies in the epidemiology of tinea pedis. IX. Tinea pedis and erythrasma in new patients at a chiropody clinic. Br Med J. 1968;4(5625):228-30.

Lambert J, Richert B, Dezfoulian B, de la Brassinne M. Epidemiology, physiopathology and treatment of a frequent ailment: tinea pedis. Rev Med Liege. 2000;55(3):161-8.

Rogers D, Kilkenny M, Marks R. The descriptive epidemiology of tinea pedis in the community. Australas J Dermatol. 1996;37(4):178-84.

Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. Am Fam Physician. 2014;90(10):702-10.

Lamb L, Morgan M. Skin and soft tissue infections in the military. J R Army Med Corps. 2013;159(3):215-23.

Cohen AD, Wolak A, Alkan M, Shalev R, Vardy DA. Prevalence and risk factors for tinea pedis in Israeli soldiers. Int J Dermatol. 2005;44(12):1002-5.

Legge BS, Grady JF, Lacey AM. The incidence of tinea pedis in diabetic versus nondiabetic patients with interdigital macerations: a prospective study. J Am Podiatr Med Assoc. 2008;98(5):353-6.

Toukabri N, Dhieb C, El Euch D, Rouissi M, Mokni M, Sadfi-Zouaoui N. Prevalence, Etiology, and Risk Factors of Tinea Pedis and Tinea Unguium in Tunisia. Can J Infect Dis Med Microbiol. 2017;2017:6835725.

Canavan TN, Elewski BE. Identifying Signs of Tinea Pedis: A Key to Understanding Clinical Variables. J Drugs Dermatol. 2015;14(10):s42-7.

Brooks KE, Bender JF. Tinea pedis: diagnosis and treatment. Clin Podiatr Med Surg. 1996;13(1):31-46.

Blutfield MS, Lohre JM, Pawich DA, Vlahovic TC. The Immunologic Response to Trichophyton Rubrum in Lower Extremity Fungal Infections. J Fungi (Basel). 2015;1(2):130-7.

Koga T, Shimizu A, Nakayama J. Interferon-gamma production in peripheral lymphocytes of patients with tinea pedis: comparison of patients with and without tinea unguium. Med Mycol. 2001;39(1):87-90.

Al Hasan M, Fitzgerald SM, Saoudian M, Krishnaswamy G. Dermatology for the practicing allergist: Tinea pedis and its complications. Clin Mol Allergy. 2004;2(1):5.

Daeschlein G, Rauch L, Haase H. Influence of nutrition, common autoimmune diseases and smoking on the incidence of foot mycoses. Hautarzt. 2019;70(8):581-93.

Hegyi E, Hudáková G, Buchvald J, Hrabinová S, Bakos J. The specificity of mycins and their importance in the diagnosis of dermatomycoses. Allerg Asthma (Leipz). 1967;13(4):164-76.

Nakamura A, Uratsuji H, Yamada Y, Hashimoto K, Nozawa N, Matsumoto T. Anti-inflammatory effect of lanoconazole on 12-O-tetradecanoylphorbol-13-acetate- and 2,4,6-trinitrophenyl chloride-induced skin inflammation in mice. Mycoses. 2020;63(2):189-96.

Ogasawara Y. Prevalence and patient's consciousness of tinea pedis and onychomycosis. Nihon Ishinkin Gakkai Zasshi. 2003;44(4):253-60.

Drago L, Micali G, Papini M, Piraccini BM, Veraldi S. Management of mycoses in daily practice. G Ital Dermatol Venereol. 2017;152(6):642-50.